23andMe is a genomics and biotechnology company that allows users to discover ancestry by submitting a cheek swab for genetic testing. They’ve announced that they’re planning to go public via a SPAC, sometime before June 2021. This could be an ideal RISK Rituals. It gives us a news hook for looking at SPACs in general, and also touches on some of the privacy issues that we want to explore.

RISK Rituals

Website

Facebook

Twitter

Do “blue chip” stocks still exist?

Idea

Dec 31, 2021

There was an idea for a long time of “blue chip” stocks — huge companies with excellent reputations that could be considered reliable earners. Can we have that much confidence in anything anymore?

⁠

Want to print your doc?
This is not the way.

Try clicking the ⋯ next to your doc name or using a keyboard shortcut (

CtrlP

) instead.